PLEASANTON, Calif., Dec. 22, 2014 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on January 13, 2015. Robert S. Weiss, President and Chief Executive Officer, will represent the Company in a presentation scheduled to begin at 3:00PM PT (6:00PM ET).
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at http://investor.coopercos.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in
Pleasanton, CA, Cooper has approximately 9,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
CONTACT: Kim Duncan
Vice President, Investor Relations
ir@cooperco.com
925-460-3663
Source:
The Cooper Companies, Inc.
News Provided by Acquire Media
